Components of the CDw18 leukocyte surface glycoprotein complex (Mo1/LFA-1/GP 150,95 or MAC-1, LFA-1 family) are required for some adhesion-related functions of human neutrophils (PMNs). We evaluated the ability of monoclonal antibodies (MoAb) directed against specific determinants on the CDw18 glycoproteins to inhibit neutrophil adherence to cultured human endothelial cells (EC) stimulated by a variety of agonists, including thrombin and leukotriene C4, which induce the EC-dependent adhesion of PMNs. MoAb 60.3, an antibody that binds to an epitope common to the 3 heterodimer subunits of the neutrophil CDw18 complex, potently inhibited (90-100%) the rapid (5-30 minute) adherence response stimulated by N-formyl-methyionyl-leucyl-phenylalanine, leukotriene B4, plateletactivating factor, phorbol myristate acetate, Ionophore A23187, and tumor necrosis factor. MoAbs directed against epitopes on the alpha polypeptide of the CD11b (Mol, MAC-1) heterodimer also inhibited PMN adherence to EC and to cell-free surfaces induced by these agonists. In contrast, the anti-CDw18 MoAbs had a trivial effect on maximal EC-dependent neutrophil adherence stimulated by thrombin and leukotriene C4, and incompletely inhibited PMN adherence induced by these agonists under submaximal conditions. These findings indicate that there is an alternative mechanism for neutrophil adherence, presumably resulting from molecular alterations of the EC surface, that does not require the PMN CDw18 glycoproteins. They also suggest that the inability to adhere to endothelium may not completely account for the defect in […] antibody that binds to an epitope common to the 3 heterodimer subunits of the neutrophil CDw18 complex, potently inhibited (90-100%) the rapid (5-30 minute) adherence response stimulated by N-formyl-methionyl-leucyl-phenylalanine, leukotriene B4, platelet-activating factor, phorbol myristate acetate, lonophore A23187, and tumor necrosis factor. MoAbs directed against epitopes on the a polypeptide of the CDllb (Mol, MAC-1) heterodimer also inhibited PMN adherence to EC and to cell-free surfaces induced by these agonists. In contrast, the anti-CDwl8 MoAbs had a trivial effect on maximal ECdependent neutrophil adherence stimulated by thrombin and leukotriene C4, and incompletely inhibited PMN adherence induced by these agonists under submaximal conditions. These findings indicate that there is an alternative mechanism for neutrophil adherence, presumably resulting from molecular alterations of the EC surface, that does not require the PMN CDw18 glycoproteins. They also suggest that the inability to adhere to endothelium may not completely account for the defect in chemotaxis that is observed in vivo in neutrophils that are deficient in the CDw18 complex.
Introduction
The adherence of neutrophils (PMNs, granulocytes) to the endothelium is a key event in acute inflammation. It is required for an effective chemotactic response and also for some forms of neutrophil-mediated vascular injury (1, 2) . When stimulated by specific agonists the neutrophils (3), the endothelial cells (EC)' (4, 5) , or both (6) , become adhesive, resulting in accumulation of granulocytes on the EC surface. Recently, a glycoprotein that is involved in adhesive interactions has been identified on the surface of activated human neutrophils and has been designated the CDl lb or Mol glycoprotein (7) (8) (9) (10) . The molecule is one of a family of three heterodimers, each consisting of a common ,3 polypeptide chain and a variable a-chain, termed the CDwl 8 complex (1, (7) (8) . Alternatively the heterodimers have been called the LFA-1, MAC-1, or the Mol/LFA-l/GP 150,95 glycoprotein family (9, 10) . The CDwl 8 complex is critically involved in a variety of functions of neutrophils and other leukocytes. Studies with antibodies directed against specific epitopes on the glycoproteins (10) , and of leukocytes from patients who have an inherited deficiency of the molecules (7) (8) (9) (10) (11) , have indicated that one or more components of the CDw 18 complex is required for effective neutrophil chemotaxis and for other adhesion-related functions. Endothelial cell-dependent neutrophil adhesion stimulated by some agonists (8) , as well as increased neutrophil adhesiveness resulting from the action of agonists that directly activate the granulocytes (7, 10) , appears to be largely mediated by expression of the neutrophil CDwl 8 complex.
In previous studies we found that thrombin and the sulfidopeptide leukotriene, LTC4, cause the endothelial cell-dependent adherence of neutrophils to human endothelial monolayers (4, 12) . In the experiments described in this report we examined the effect of monoclonal antibodies directed against the CDwl 8 glycoproteins of PMNs on adhesion stimulated by thrombin and LTC4. The results indicate that the neutrophil adhesive glycoproteins are not absolutely required for adherence to endothelium stimulated by these agonists, in contrast to their requirement in adhesion induced by N-formyl-methionyl-leucyl-phenylalanine (fMLP), leukotriene B4, and a variety of other agonists that directly enhance the adhesiveness of neutrophils.
Methods
Human endothelial cells. Monolayers of umbilical vein EC were cultured as described (4) . Only tightly confluent, primary monolayers of EC were used for these experiments.
Adherence of neutrophils to EC monolayers. The labeling of suspensions ofisolated human PMNs with "'In oxine and quantitation of the adherence of the radiolabeled granulocytes to endothelial monolayers were done exactly as described (4 Adherence of neutrophils to cell-free surfaces. The adhesion of "'In-labeled granulocytes to polystyrene petri dishes preincubated with human serum albumin or with 0.2% gelatin was measured as described ( 13 (6) (7) (8) 14) that precipitates all of the polypeptide chains of the multimeric CDw18 cell surface glycoprotein complex (7) , indicating that it is directed against an epitope on the common beta chain or against an epitope defined by the quarternary structure of the molecules (7, 10) . MoAb 60.1 is an IgGl antibody directed against an epitope on the a chain polypeptide (am or a,) (7, 9, 10) of the CDl lb (MAC-1, Mol) heterodimer (7) . Both MoAb 60.3 and 60.1 have been shown to inhibit neutrophil adhesive functions in response to some agonists (7, 10 (10, 14) . It inhibits a number of neutrophil functions that are dependent on adhesion (7, 8) . Therefore, we evaluated the ability of MoAb 60.3 to inhibit PMN adherence in response to soluble stimuli that directly enhance the adhesiveness of neutrophils. In preliminary experiments we found that MoAb 60.3 inhibited fMLPstimulated PMN adherence to EC monolayers and to albumin-treated petri dishes in a concentration-dependent fashion with maximal inhibition at 10 ,ug/ml. This result is similar to the concentration dependence previously reported by Harlan et al., using other agonists (16) . A time course (1-30 min) demonstrated that maximal inhibition occurred when PMN suspensions were pretreated with MoAb 60.3 (10 ,ug/ml) for as little as 5 min at 22°C before stimulation with fMLP. In eight subsequent experiments in which PMNs were pretreated with MoAb 60.3 and their adherence to EC in response to fMLP was measured, the mean inhibition was 98% (Table I and Fig.  1 ). In several of these experiments the adherence of fMLPstimulated PMNs was reduced below the level of basal, unstimulated adherence in the presence of MoAb 60.3. We then examined the effect of the antibody on adherence stimulated by other soluble agonists added to neutrophil suspensions in the fluid phase, using concentrations of the agonists that caused maximal or near-maximal adhesion. MoAb 60.3 inhibited adherence to EC in response to LTB4, PAF, TNF, PMA, and calcium ionophore A23187 by 93-100% under these conditions (Table I ). The antibody also potently inhibited PMN aggregation stimulated by fMLP, LTB4, PAF, CSa fragments in zymosan-activated plasma, and PMA (not shown), and inhibited neutrophil adherence to cell-free surfaces (Table I ). In 
91±6 (2) 20 (1) In each experiment neutrophil suspensions that had been preincubated with MoAb (60.3 -10 gg/ml; 60.1 -40 ,ug/ml; 60. (Table I) , we examined its effect on adherence stimulated by thrombin. Human a-thrombin induces increased neutrophil adhesion by an endothelial cell-dependent mechanism, and does not directly alter neutrophil adhesiveness (4). In four experiments, MoAb 60.3 caused a mean 18% inhibition of the adherence stimulated by 2 U/ml thrombin, whereas it completely inhibited fMLP-stimulated adherence in parallel incubations (Fig.  1) . Thrombin-stimulated adherence was unchanged or slightly enhanced by MoAb 60.5. We found similar results when endothelial cells were preincubated with thrombin (5 min, 37°C) followed by washing and the addition of control or MoAbtreated PMNs, or when the thrombin was added to MoAbpretreated neutrophil suspensions in the presence of endothelial cells (Methods). Increasing the concentration of MoAb 60.3 from 1O to 40 ug/ml did not further increase the inhibition.
The experiments in Fig. 1 demonstrate that MoAb 60.3 had a minor effect on PMN adherence caused by concentrations of thrombin that induce maximal EC-dependent adhesion (4, 13) , suggesting that the PMN CDw18 complex plays a minor role and is not absolutely required for neutrophil adherence to thrombin-stimulated endothelium under these conditions. To determnine ifthe neutrophil CDw1 8 glycoproteins are required for submaximal endothelial cell-dependent adhesion, we examined the effect of MoAb 60.3 on neutrophil adherence stimulated by lower concentrations of thrombin. In two experiments MoAb 60.3 reduced PMN adherence induced by submaximal concentrations of thrombin (0.1-0.5 U/ml) by 22-40%. This result suggests that the neutrophil glycoproteins play a greater role in the adhesive interaction when EC are activated under submaximal conditions. However, the adherence of MoAb 60.3-treated PMNs remained significantly elevated at suboptimal concentrations of thrombin and was not reduced to basal levels at any thrombin concentration (Fig. 2) .
Effect ofMoAb 60.3 on EC-dependent neutrophil adherence stimulated by LTC4. We then examined the effect of MoAb 60.3 on neutrophil adherence induced by LTC4, an agonist that also acts by an endothelial cell-dependent mechanism (12) . The LTC4-stimulated adhesiveness of the endothelial cells is both concentration-and time-dependent (12); in contrast to thrombin, which causes maximal adherence at 5-10 min (4), LTC4-induced neutrophil adherence continuously increases during this period, with a peak at 30 min (12) . Therefore we studied the ability of MoAb 60.3 to inhibit submaximal (at 5 miii) and maximal (at 30 min) LTC4-induced adherence. At 5 min, the adherence of PMNs treated with MoAb 60.3 (10 ,g/ml) was 15±10% compared to 22±7% for PMNs treated with control buffer (n = 4, P = 0.05 by paired t test), representing a mean 65% inhibition (range 9-100%) (Figs. 3 A,  4) . At 30 min the adherence of MoAb 60.3-treated PMNs was 35±11% versus 42±15% for control neutrophils (n = 7, P = 0.04 by paired t test), a mean 21% inhibition (range 3-36%). In 2 of these experiments there was essentially no inhibition of LTC4-induced adherence by MoAb 60.3 at 30 min (5% or less; Fig. 4 ), although the antibody inhibited adherence stimulated by one or more of the agonists shown in Table I (Fig. 3 B) .
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Effect ofmonoclonal antibodies directed at other epitopes of CDwJ8 on neutrophil adherence. MoAb 60.1 (40 ,ug/ml) inhibited fMLP-, LTB4-, PAF-, and PMA-stimulated PMN adherence to EC and to cell-free surfaces by 70-99% (Table I ). In contrast, in three experiments the antibody inhibited LTC4-stimulated adherence (10-6 M, 30 min) by 29±19% (range 8-43%). In three additional experiments MoAb 60.1 inhibited thrombin-stimulated adherence (2 U/ml, 5 min) by 33% or less. In two experiments MoAb Mo 1 a inhibited PMA-induced neutrophil adherence to EC by 61-75% whereas ascites fluids containing control antibody did not inhibit adherence. In parallel incubations in these experiments the adherence of MoAb Molca-treated neutrophils was the same as, or greater than, that of control antibody-treated neutrophils in response to thrombin (2 U/ml, 5 min) or LTC4 (10-6 M, 30 min).
Discussion
Identification of the molecular mechanisms involved in neutrophil adherence to endothelium promises to be a key to deciphering processes that control acute inflammation, contribute to inflammatory vascular injury, and that are disrupted in certain life-threatening syndromes of leukocyte dysfunction (17) . Recent observations indicate that the CD1 lb (MAC-1, Mo 1) heterodimer ofthe CDw 18 glycoprotein complex is critically involved in neutrophil adhesive interactions including aggregation, adhesion to nonbiologic surfaces, and adhesion to endothelium (6) (7) (8) (9) (10) (11) . In this study we found that a monoclonal antibody directed against a common determinant on the glycoproteins ofthe leukocyte CDw18 complex, MoAb 60.3, and antibodies directed against epitopes on the a polypeptide chain of the CDl lb heterodimer, MoAbs 60.1 and Mola, inhibited neutrophil adherence to endothelium and to cell-free surfaces stimulated by a variety of agonists of different classes (Table I) . The relative potency of the antibodies as inhibitors of PMN adherence to EC (MoAb 60.3 > 60.1 2 Mo 1 a, Table I ) was similar to the hierarchy of inhibition of leukocyte adhesiondependent functions by other MoAbs directed against specific epitopes on the a or ,3 polypeptides (18). The results in Table I demonstrate that one mechanism for rapid adhesion of PMNs to endothelium induced by these agonists in the fluid phase involves activation of the neutrophils and expression of the adhesive glycoprotein. For some of the agonists, particularly fMLP and LTB4 (3, 19) , the relative contributions of a direct effect on the neutrophils and an endothelial cell-dependent mechanism has been previously questioned (1-4, 19, 20) .
Human TNFa causes both a direct enhancement ofneutrophil adhesiveness as well as increased neutrophil adherence resulting from an alteration in the EC surface, depending on the time of incubation (6, 8) . The rapid (30 min), direct increase in PMN adhesiveness induced by TNFa is reported to be completely inhibited by treatment with MoAbs 60.3 and 60.1 (6) , an observation that is confirmed by the data in Table I . The findings in Table I are also consistent with previously published reports of the effects of MoAbs 60.3 and 60.1 on PMN adherence induced by PMA, To A23187, and fMLP under different temporal conditions (7, 16) and with observations that anti-Mo 1 a inhibits neutrophil aggregation induced by fMLP and CSa (10) .
MoAb 60.3 was a particularly useful reagent because of its potency and because it is directed against an epitope found on each of the heterodimeric members of the CDw18 complex and therefore against the GP 150,95 as well as the CDI lb (Mo 1, MAC-1) heterodimers (1, 7, 10) . Both of these glycoproteins are expressed on the surface of activated PMNs and may be important in their adhesive responses (7, 16, 18, 21) . Furthermore, treatment of normal PMNs with MoAb 60.3 reproduces the adherence-dependent functional deficiencies found in granulocytes from patients that are genetically deficient in the CDw1 8 molecules (7, 16) . Therefore, we examined the effects of MoAb 60.3 on endothelial cell-dependent PMN adherence stimulated by thrombin and LTC4 in detail, and in selected experiments compared them to the effects of monoclonal antibodies directed against other epitopes on the CDw1 8 glycoproteins. In each experiment we did parallel incubations using fMLP or another agonist that directly enhanced the adhesiveness of the neutrophils (Table I) to document the efficacy of the anti-CDwl 8 antibodies.
In contrast to adherence stimulated by the agonists in Table I cant differences in the endothelial cell-dependent neutrophil adhesion induced by these cytokines (5, 6, 8) compared to that induced by thrombin and LTC4 (4, 12, 13) , and that different molecular mechanisms are involved. However Pohlman et al. also noted that PMNs treated with MoAb 60.3, and neutrophils from a CDwl 8-deficient patient, adhered to TNF-, interleukin 1-, and endotoxin-treated EC, albeit much less avidly than did control leukocytes (8) . This observation is consistent with the hypothesis that one or more proadhesive molecules on the endothelial surface mediate the interaction with PMNs without an absolute requirement for the neutrophil glycoproteins. The identity of the endothelial cell adhesive molecule(s) remains to be determined. We previously suggested that PAF that is endogenously synthesized by thrombin-or LTC4-activated EC may directly mediate the adhesive interaction (4, 12, 13) . Taken at face value, the experiments in Table I argue against this hypothesis since MoAb 60.3 inhibited PMN adherence induced by exogenous PAF but had little effect on maximal adherence stimulated by thrombin or LTC4 (Figs.  1-4 ). However, it is possible that PAF associated with a biologic surface (i.e. the plasma membrane of the EC) interacts with the PMN in a different way from micellar PAF presented in solution. In the first condition the PAF will likely interact with a localized part of the neutrophil plasma membrane in vectorial fashion, whereas in the second condition there will be global presentation of the PAF molecules to the PMN surface. The mechanisms involved in the adhesive interaction may vary in the two situations. In addition, the motion and redistribution ofreceptors in the neutrophil plasma membrane (22) may vary when PMN adhesion occurs in one condition as opposed to the other; neutrophil receptor mobility may also vary when PMNs adhere to the altered surface of an activated endothelial cell, rather than a quiescent EC, since the nature of the surface influences these events (22, 23) . We cannot exclude the possibility there is localized expression of the CDwl 8 glycoproteins on an area of the PMN membrane adjacent to the EC when the neutrophils are activated by PAF associated with the endothelial surface and that the anti-CDw1 8 antibodies were excluded from this microenvironment in our experiments. Finally, it is also possible that the MoAb 60.3-inhibitable PMN adherence to EC stimulated by thrombin and LTC4 (20-65%, depending on whether the EC are maximally or submaximally activated; Results) is mediated by endogenously synthesized PAF, whereas the remainder is mediated by a second molecular species (4 (16, 24) or the partial ability to undergo enhanced adherence by an EC-dependent mechanism (8) . Similar events may occur in vivo since neutrophils accumulate in microvessels adjacent to sites of infection but do not migrate into extravascular tissues in some patients with CDwl 8 deficiency (1 1). These observations suggest that adhesion is required, but not sufficient, for directed PMN migration, further suggesting that CDwl 8 deficiency results in additional defects in chemotaxis and other complex, adhesion-related, neutrophil functions. The glycoproteins may be important in transducing signals from the external environment to intracellular regulatory systems. This possibility is suggested by observations that other surface glycoproteins that are important in adhesion-related functions have extensive intracellular domains providing sites for interaction with cytoplasmic proteins and cytoskeletal elements (25) and that key regulatory proteins are concentrated at points of cell-cell adhesion in some mammalian cells (26) .
